Results 141 to 150 of about 6,369 (156)

Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk of Hospitalization?

Annals of Pharmacotherapy, 2006
Derek Weycker, Gerry Oster, Andrew G Glass   +2 more
exaly  

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

Annals of Oncology, 2020
M Mates, N Califaretti, J Raphaël
exaly  

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada

Oncologist, 2019
Sumimasa Nagai, Bartlett J Witherspoon, Chadi Nabhan   +2 more
exaly  

Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2015
Justin G Horowitz, Paul J Shaughnessy, CARLOS Bachier   +2 more
exaly  

Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics

BioDrugs, 2015
Johann Holzmann, Sörgel Fritz
exaly  

Use of Filgrastim and Pegfilgrastim to Support Delivery of Chemotherapy

BioDrugs, 2012
Ruth Pettengell, Michael Green, Pettengell Ruth   +2 more
exaly  

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature

Leukemia Research, 2007
Pellegrino Musto, Potito Rosario Scalzulli, Elisabetta Terruzzi   +2 more
exaly  

Filgrastim

Reactions Weekly, 1995
openaire   +1 more source

Filgrastim

Reactions Weekly, 2014
openaire   +2 more sources

Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®

BioDrugs, 2012
exaly